BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35328735)

  • 21. Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny.
    Kapoor H; Agrawal DK; Mittal SK
    Transl Res; 2015 Jul; 166(1):28-40. PubMed ID: 25701368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile acids but not acidic acids induce Barrett's esophagus.
    Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
    Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF; Krishnan K; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
    Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
    Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro.
    Tselepis C; Morris CD; Wakelin D; Hardy R; Perry I; Luong QT; Harper E; Harrison R; Attwood SE; Jankowski JA
    Gut; 2003 Feb; 52(2):174-80. PubMed ID: 12524396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.
    Deissova T; Cvanova M; Kala Z; Jiraskova Zakostelska Z; Dolina J; Kunovsky L; Kroupa R; Pavlovsky Z; Lipovy B; Danek Z; Izakovicova Holla L; Urban O; Navratil V; Lischke R; Harustiak T; Grolich T; Prochazka V; Slaby O; Borilova Linhartova P
    Dis Markers; 2022; 2022():8790748. PubMed ID: 36092955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
    Grady WM; Yu M
    Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
    Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
    Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.
    Kong J; Whelan KA; Laczkó D; Dang B; Caro Monroig A; Soroush A; Falcone J; Amaravadi RK; Rustgi AK; Ginsberg GG; Falk GW; Nakagawa H; Lynch JP
    Mol Carcinog; 2016 Nov; 55(11):1526-1541. PubMed ID: 26373456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
    Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
    Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
    Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.